# TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers

> **NCT00389636** · NA · UNKNOWN · sponsor: **Solsys Medical LLC** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** TheraGauze
- **DRUG:** Regranex

## Key facts

- **NCT ID:** NCT00389636
- **Lead sponsor:** Solsys Medical LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-09
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389636, "TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00389636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*